Publicacions en col·laboració amb investigadors/es de Universidad de Cantabria (40)

2024

  1. A Missense Variant in TP53 Could Be a Genetic Biomarker Associated with Bone Tissue Alterations

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  2. High Frequencies of Genetic Variants in Patients with Atypical Femoral Fractures

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

  3. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

2022

  1. Analysis of Bone Histomorphometry in Rat and Guinea Pig Animal Models Subject to Hypoxia

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  2. Clinical practice guidelines for postmenopausal, glucocorticoid-induced and male osteoporosis: 2022 update

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 13-33

  3. Executive summary clinical practice guideline of postmenopausal, glucocortcioid-induced and male osteoporosis (2022 update). Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM)

    Revista Clinica Espanola, Vol. 222, Núm. 7, pp. 432-439

  4. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  5. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  6. Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

    Journal of Bone and Mineral Research

2021

  1. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial

    Journal of Bone and Mineral Research, Vol. 36, Núm. 10, pp. 1967-1978

  2. Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy

    Clinical and experimental rheumatology, Vol. 39, Núm. 1, pp. 105-114

  3. Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID)

    Wiener klinische Wochenschrift, Vol. 133, Núm. 7-8, pp. 303-311

  4. Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study

    Clinical Transplantation, Vol. 35, Núm. 5

2020

  1. Specialised headache units, a feasible alternative in Spain

    Revista de Neurologia, Vol. 71, Núm. 6, pp. 199-204

2018

  1. Diagnosis, management and mortality in acute aortic syndrome: results of the Spanish Registry of Acute Aortic Syndrome (RESA-II)

    European heart journal. Acute cardiovascular care, Vol. 7, Núm. 7, pp. 602-608

2017

  1. SNPs in bone-related miRNAs are associated with the osteoporotic phenotype

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Exon array analysis reveals genetic heterogeneity in atypical femoral fractures. A pilot study

    Molecular and Cellular Biochemistry, Vol. 409, Núm. 1-2, pp. 45-50

2014

  1. Polymorphisms of the farnesyl diphosphate synthase gene modulate bone changes in response to atorvastatin

    Rheumatology International, Vol. 34, Núm. 8, pp. 1073-1077